Skip to content
Search

Latest Stories

US health regulator approves Cipla’s inhalation solution

Shilpa Sharma
By Shilpa SharmaJun 24, 2021
Shilpa Sharma
See Full Bio

PHARMACEUTICAL major Cipla received final consent from the US health regulator for Arformoterol Tartrate inhalation solution.

The approved product is used to treat conditions like chronic bronchitis and emphysema in the US market.

The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said in a regulatory filing on Wednesday (23).

It is a generic version of Sunovion Pharmaceuticals Inc's Brovana.

Brovana is used in maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Brovana had sales of around $438 million (£314m) in the US for the 12-month period ending April 2021.

The new product is available for shipping immediately, Cipla said.

ciplaus

Related News

Sanjay Bhandari's extradition appeal opens in London
Business

Sanjay Bhandari's extradition appeal opens in London

Rupert Murdoch looks on as he walks on the day of the hearing on the contentious matter of succession of Rupert Murdoch's global television and publishing empire, in Reno, Nevada, US, September 23, 2024. (Photo: Reuters)
Business

Murdoch's bid to secure eldest son's control of media empire fails

Kamlesh Pattni faces UK sanctions for illicit gold trade
Business

Kamlesh Pattni faces UK sanctions for illicit gold trade

Sanjay Malhotra speaks during the 67th Foundation Day of the Directorate of Revenue Intelligence (DRI) in New Delhi on December 4, 2024. (Photo: Getty Images)
Business

India appoints Sanjay Malhotra as new central bank governor

EasternEye

More For You

Bank of England

The Bank of England has indicated it may accept inflation above its 2 per cent target for a period

REUTERS

Bank of England can tolerate inflation above 2 per cent target, Bailey signals

  • The Bank of England has indicated it may accept inflation above its 2 per cent target for a period.
  • Andrew Bailey warned that acting too aggressively could create unnecessary volatility.
  • Inflation is expected to rise further as higher costs filter through the economy.

The Bank of England has signalled it is prepared to tolerate inflation above its 2 per cent target for a period, as policymakers try to balance rising prices against signs of weakness in the UK economy.

Speaking in Reykjavik, Iceland, Bank of England Governor Andrew Bailey suggested that bringing inflation back to target immediately may not be the best approach while businesses and households continue to face economic uncertainty.

Keep ReadingShow less